Popular GLP-1 and related injection names include Wegovy, Ozempic, Saxenda, Mounjaro, and Zepbound
GLP-1 drugs mimic the effects of this hormone
Vitamin D deficiency was most common, affecting 13.6% within 12 months
Treatment History Provide a timeline of prior therapies: compression, weight management, physical therapy, antibiotics, procedural interventions, and outcomes for each
Intended Use: For Laboratory Research Use Only Key Characteristics of Retatrutide (60 mg) Triple Receptor Agonist (Research Context): Designed to engage GLP-1, GIP, and glucagon receptors in experimental systems
The 12mg dose is the highest tested in trials and produced the most weight loss (up to 28.7% of body weight)